Cargando…

Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units

Infections with multidrug-resistant organisms among patients in intensive care units (ICUs) are associated with high mortality. Among multidrug-resistant organisms, carbapenem-resistant Enterobacterales (CRE) harbor important pathogens for healthcare-associated infections, including pneumonia, bacte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Jongyoun, Kim, Kye-Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Critical Care Medicine 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435449/ https://www.ncbi.nlm.nih.gov/pubmed/34380190 http://dx.doi.org/10.4266/acc.2021.00409

Ejemplares similares

588. Ceftolozane/Tazobactam Susceptibility of Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacterales Isolates in a Tertiary Hospital in Korea
por: Kim, Kye-Hyung, et al.
Publicado: (2023)

Prevalence and Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study
por: Kang, Jin Suk, et al.
Publicado: (2019)

Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China
por: Yin, L., et al.
Publicado: (2021)

Epidemiology and Mortality Analysis Related to Carbapenem-Resistant Enterobacterales in Patients After Admission to Intensive Care Units: An Observational Study
por: Yoo, Eun Hyung, et al.
Publicado: (2023)

A Literature Overview of Secondary Peritonitis Due to Carbapenem-Resistant Enterobacterales (CRE) in Intensive Care Unit (ICU) Patients
por: Di Franco, Sveva, et al.
Publicado: (2022)

1250. Prevalence and Risk Factors for Acquiring Carbapenem-Resistant Enterobacteriaceae in an Intensive Care Unit at a Tertiary Hospital
por: Kang, Jin Suk, et al.
Publicado: (2018)

724. Prevalence and Risk Factors for Carbapenem Resistant Enterobacterales Colonization on Admission to Two Intensive Care Units in India
por: Mansoor, Armaghan-e-Rehman, et al.
Publicado: (2023)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales
por: Rabaan, Ali A., et al.
Publicado: (2022)

Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales
por: Howard-Anderson, Jessica R., et al.
Publicado: (2022)

Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
por: Bhowmick, Tanaya, et al.
Publicado: (2020)

2749. Impact of rapid carbapenemase identification on management of patients with carbapenem-resistant Enterobacterales infections
por: Burke, Elysia, et al.
Publicado: (2023)

A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques
por: Caliskan-Aydogan, Oznur, et al.
Publicado: (2023)

Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit
por: Pace, Maria Caterina, et al.
Publicado: (2023)

Synergy between infection control and antimicrobial stewardship programs to control carbapenem-resistant Enterobacterales
por: Cornistein, Wanda, et al.
Publicado: (2023)

An observational study on carbapenem-resistant Enterobacterales (CRE) colonisation and subsequent risk of infection in an adult intensive care unit (ICU) at a tertiary care hospital in India
por: Sharma, Kirtika, et al.
Publicado: (2023)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
por: Band, Victor I., et al.
Publicado: (2021)

The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital
por: Tangsawad, Watcharaphon, et al.
Publicado: (2022)

CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

Efficacy of Active Rapid Molecular Screening and IPC Interventions on Carbapenem-Resistant Enterobacterales Infections in Emergency Intensive Care Units without Enough Single-Room Isolation
por: Yang, Simin, et al.
Publicado: (2023)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
por: Kaye, Keith S., et al.
Publicado: (2023)

2477. Characteristics of patients infected with Carbapenem-resistant Acinetobacter baumannii complex and Carbapenem-resistant Enterobacterales in Tennessee, 2016–2021
por: Patel, Dipen, et al.
Publicado: (2023)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales
por: Takei, Kentarou, et al.
Publicado: (2023)

PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales
por: Paterson, David L, et al.
Publicado: (2021)

1029. Increased Mortality in Hospital-Onset Carbapenem-Resistant Enterobacterales Bloodstream Infections
por: Boutzoukas, Angelique E, et al.
Publicado: (2023)

The carbapenem inoculum effect provides insight into the molecular mechanisms underlying carbapenem resistance in Enterobacterales
por: Cartagena, Alexis Jaramillo, et al.
Publicado: (2023)

Distinctive Features of Ertapenem-Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States: A Cohort Study
por: Adelman, Max W, et al.
Publicado: (2021)

Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital
por: Salomão, Matias C, et al.
Publicado: (2023)

716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
por: Clark, Justin A, et al.
Publicado: (2023)

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
por: Abrahams, Ilhaam, et al.
Publicado: (2023)

Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals
por: Cai, Yiying, et al.
Publicado: (2022)

Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
por: Bir, Raunak, et al.
Publicado: (2022)

Aztreonam-avibactam: an option against carbapenem-resistant Enterobacterales with emerging resistance
por: Wu, Shikai, et al.
Publicado: (2022)

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar
por: Abid, Fatma Ben, et al.
Publicado: (2021)

Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018
por: Paveenkittiporn, Wantana, et al.
Publicado: (2021)

Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia
por: Alraddadi, Basem M., et al.
Publicado: (2022)

Monitoring Carbapenem-Resistant Enterobacterales in the Environment to Assess the Spread in the Community
por: Urase, Taro, et al.
Publicado: (2022)

Early Years of Carbapenem-Resistant Enterobacterales Epidemic in Abu Dhabi
por: Pál, Tibor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9i528e5if3709vlrekchlvq84